Linkcare

Linkcare Health Services SL, established on February 15, 2010, originated as a spin-off from the prestigious Hospital Clínic of Barcelona with backing from the Fundació Clínic per a la Recerca Biomèdica. The company was founded by Dr. Josep Roca, who served for many years as the director of the pulmonary functional examination laboratory at the Hospital Clínic de Barcelona and as a professor at the University of Barcelona's Faculty of Medicine and Health Sciences. Dr. Roca's extensive background, including authoring over 300 original articles, shaped the company's direction towards commercializing knowledge and products developed within the hospital, particularly focusing on chronic care to enhance patient quality of life and reduce healthcare costs.

The firm operates through three distinct yet synergistic business units. The primary offering is an Integrated Care open platform that enables diverse healthcare professionals—such as specialists, general practitioners, and nurses—to collaborate and share clinical knowledge within a patient-centric model. This platform provides a library of standard forms and activities to create integrated care plans for programs like Hospital at Home, chronicity management, and palliative care. For the clinical research sector, Linkcare provides a unit for creating research teams and designing electronic Case Report Forms (eCRFs). This tool facilitates the management of clinical trials, including patient recruitment, randomization, and follow-up.

A third key unit, Biosomic Technologies, is a research-focused division developing point-of-care in-vitro diagnostic devices. This unit concentrates on early disease screening where timely detection significantly improves patient outcomes. It operates under two brands: ONCOSOMIX for the early detection of cancer and NEUROSOMIX for neurodegenerative diseases. The technology leverages the detection of biomarkers in extracellular vesicles to identify conditions like Parkinson's disease before clinical symptoms become apparent. In response to the COVID-19 pandemic, the company established "Linkcare Bioscreening," a division capable of manufacturing millions of rapid diagnostic test kits annually for infectious diseases and tumor markers, aiming to reduce dependency on foreign supplies.

Keywords: health services, integrated care platform, medical consulting, clinical trials, eCRF, patient-centric care, chronic disease management, biosomic technologies, in-vitro diagnostics, point-of-care testing, cancer detection, neurodegenerative disease screening, ONCOSOMIX, NEUROSOMIX, Hospital Clínic de Barcelona spinoff, Josep Roca, digital health, collaborative medicine, telemedicine, biomedical research